KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) Shares Outstanding (Diluted Average) (2016 - 2025)

Edwards Lifesciences has reported Shares Outstanding (Diluted Average) over the past 15 years, most recently at $585.8 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $585.8 million for Q4 2025, down 2.25% from a year ago — trailing twelve months through Dec 2025 was $585.8 million (down 2.25% YoY), and the annual figure for FY2025 was $585.8 million, down 2.25%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $585.8 million at Edwards Lifesciences, roughly flat from $587.2 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for EW hit a ceiling of $631.7 million in Q3 2021 and a floor of $585.8 million in Q4 2025.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $610.4 million (2023), compared with a mean of $611.5 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): grew 0.46% in 2021 and later decreased 2.94% in 2023.
  • Edwards Lifesciences' Shares Outstanding (Diluted Average) stood at $631.2 million in 2021, then decreased by 1.11% to $624.2 million in 2022, then dropped by 2.37% to $609.4 million in 2023, then fell by 1.66% to $599.3 million in 2024, then decreased by 2.25% to $585.8 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $585.8 million (Q4 2025), $587.2 million (Q3 2025), and $587.9 million (Q2 2025) per Business Quant data.